Covered recipient · General Payments record
PEJMAN RAEISI-GIGLOU
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2023–2024
$528.23
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $262.03 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $78.52 | 4 |
| Abbott Laboratories | $77.14 | 1 |
| CSL Behring | $32.80 | 1 |
| PFIZER INC. | $22.11 | 1 |
| Amgen Inc. | $19.19 | 1 |
| Janssen Pharmaceuticals, Inc | $18.50 | 1 |
| Medtronic, Inc. | $13.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $77.14 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125195378 | CMS |
| Amgen Inc. | $19.19 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116036784 | CMS |
| CSL Behring | $32.80 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134621555 | CMS |
| E.R. Squibb & Sons, L.L.C. | $23.73 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101277755 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.45 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101277757 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.17 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101277759 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.17 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101277763 | CMS |
| Janssen Pharmaceuticals, Inc | $18.50 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077933967 | CMS |
| Medtronic, Inc. | $13.77 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119432721 | CMS |
| PFIZER INC. | $22.11 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131052611 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.